Dove soap maker’s shares are biggest faller on FTSE 100 after offer for consumer products arm is rebuffed
Unilever has pledged to grow its health, beauty and hygiene business as investors dumped its shares after its failed £50bn approach for GlaxoSmithKline’s consumer products arm.
GSK rejected three Unilever bids for the consumer products arm it is seeking to spin off, the last of which was worth £50bn. The pharmaceutical company on Saturday said that the offer “fundamentally undervalued” the business, which owns brands including Panadol pain relief and Sensodyne toothpaste.
